RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
CVS Health will report third-quarter earnings before the market opens Wednesday as the pharmacy and health-care provider ...
Rite-Aid filed for bankruptcy in July and closed nearly 74 stores this year. Walgreens CEO Tim Wentworth also announced ...
Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...
Mizuho lowered the firm’s price target on CVS Health (CVS) to $66 from $73 and keeps an Outperform rating on the shares. The firm cut estimates following last week’s preannouncement.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various ...